AT322739B - Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen - Google Patents

Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen

Info

Publication number
AT322739B
AT322739B AT325373A AT325373A AT322739B AT 322739 B AT322739 B AT 322739B AT 325373 A AT325373 A AT 325373A AT 325373 A AT325373 A AT 325373A AT 322739 B AT322739 B AT 322739B
Authority
AT
Austria
Prior art keywords
thia
aza
bicyclo
oxo
oct
Prior art date
Application number
AT325373A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AT322739B publication Critical patent/AT322739B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT325373A 1972-04-13 1973-04-12 Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen AT322739B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH542672A CH582709A5 (en) 1972-04-13 1972-04-13 7-beta-amino-ceph-3-em 4-carboxylic acid derivs - antibiotics

Publications (1)

Publication Number Publication Date
AT322739B true AT322739B (de) 1975-06-10

Family

ID=4293375

Family Applications (2)

Application Number Title Priority Date Filing Date
AT434574A AT323893B (de) 1972-04-13 1973-04-12 Verfahren zur herstellung von 8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-en-verbindungen
AT325373A AT322739B (de) 1972-04-13 1973-04-12 Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT434574A AT323893B (de) 1972-04-13 1973-04-12 Verfahren zur herstellung von 8-oxo-5-thia-1-azabicyclo (4,2,0) oct-2-en-verbindungen

Country Status (5)

Country Link
JP (1) JPS4913194A (de)
AT (2) AT323893B (de)
CH (1) CH582709A5 (de)
NL (1) NL7305154A (de)
SE (1) SE416732B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60172986A (ja) * 1984-02-17 1985-09-06 Fujisawa Pharmaceut Co Ltd 8−オキソ−5−チア−1−アザビシクロ〔4.2.0〕オクト−2−エン−2−カルボン酸エステルの製造法

Also Published As

Publication number Publication date
AT323893B (de) 1975-08-11
NL7305154A (de) 1973-10-16
JPS4913194A (de) 1974-02-05
CH582709A5 (en) 1976-12-15
SE416732B (sv) 1981-02-02

Similar Documents

Publication Publication Date Title
ATA779373A (de) Verfahren zur herstellung von neuen a-phenylindolderivaten
AT342556B (de) Verfahren zur herstellung von neuen 1,2,2,2-tetrafluorathylathern
AT328078B (de) Verfahren zur herstellung von neuen cyanomethylthioacetylcephalosporinen
AT324338B (de) Verfahren zur herstellung von neuen 2,6-diamino-dihydropyridinen
AT331806B (de) Verfahren zur herstellung von neuen 1,2,4-triazin-di-n-oxiden(1,4)
AT342564B (de) Verfahren zur herstellung von neuen 11,12-secoprostaglandinen
AT326842B (de) Verfahren zur herstellung von neuen 9,10-secoöstran-derivaten
AT328452B (de) Verfahren zur herstellung von neuen 1,4-dihydrochinolinen
AT326145B (de) Verfahren zur herstellung von neuen phosphonoureidoverbindungen
AT328459B (de) Verfahren zur herstellung von neuen 1,3,5-triazinen
AT322739B (de) Verfahren zur herstellung von neuen 8-oxo-thia-l-aza-bicyclo(4,2,0)oct-2-en-verbindungen
AT322104B (de) Verfahren zur herstellung von neuen pyrono-rifamycinen
AT352731B (de) Verfahren zur herstellung von neuen 6,11- dihydrodibenzothiepin-11-on-verbindungen
AT331203B (de) Verfahren zur herstellung von 1,2-dichlorathan
AT323885B (de) Verfahren zur herstellung von neuen 3-formylrifamycinazinen
AT335444B (de) Verfahren zur herstellung von neuen 6,7-dichlor-1-indanonverbindungen
AT328631B (de) Verfahren zur herstellung von neuen 9,10-seco-ostran-derivaten
AT342025B (de) Verfahren zur herstellung von neuen 2- (alfa-di-substituierten-aminobenzyl) -propandiolen- (1,3)
ATA141474A (de) Verfahren zur herstellung von neuen 1,1-diphenyl-3-aminopropanolen-(2)
AT334914B (de) Verfahren zur herstellung von neuen tetrasila-adamantan-verbindungen
AT323345B (de) Verfahren zur herstellung von neuen 15 alfa, 16 alfa-methylen-5 alfa-androstanen
ATA646772A (de) Verfahren zur herstellung von neuen substituierten n-carbamoyloxyphenylcarbamaten
AT335627B (de) Verfahren zur herstellung von neuen 3',4'-anhydro-alfa,l-talomethylosiden
AT337684B (de) Verfahren zur herstellung von neuen hexahydro-cyclopenta (b) furanderivaten
AT331422B (de) Verfahren zur herstellung von neuen digitoxigenin-l-rhamnosid-cyclocarbonaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee